111 Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
111 Capital's ALNY Position: Q2 2026 in Review
111 Capital increased its Alnylam Pharmaceuticals (ALNY) stake by 262% in Q2 2026, buying an estimated $527K and bringing the position to 2,412 shares worth $726K. The position accounts for 0.12% of the portfolio, ranked #167.
111 Capital first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- 111 Capital held 2,412 shares of Alnylam Pharmaceuticals worth $726K as of Q2 2026.
- 111 Capital bought 1,746 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $527K.
- Alnylam Pharmaceuticals made up 0.12% of 111 Capital's portfolio in Q2 2026, its #167 holding.
- 111 Capital first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.